Silalahi Todung D A, Suwita Christopher S
Internal Medicine Department, Krida Wacana Christian University, Indonesia.
Internal Medicine Department, Jakarta Heart Center Hospital, Indonesia.
Respir Med Case Rep. 2021;34:101473. doi: 10.1016/j.rmcr.2021.101473. Epub 2021 Jul 9.
Even after more than a year, novel Coronavirus disease-19 (COVID-19) clinical presentation and complications are still being reported. We present a 75-year-old patient with culture-negative pleural empyema a month after COVID-19 resolution without re-infection. We hypothesize that culture-negative empyema can be present in patients with immune defect, e.g., elderly or diabetic patients, and prior antibiotic exposure. Empyema after COVID-19 resolution may be related to delayed inflammation improvement in chronic disease, which resulted in the patient's more vulnerability to secondary infection.
即使在一年多之后,新型冠状病毒肺炎(COVID-19)的临床表现和并发症仍不断有报道。我们报告一例75岁患者,在COVID-19痊愈后一个月出现培养阴性的胸腔积脓,且无再次感染。我们推测,培养阴性的积脓可能出现在免疫缺陷患者中,如老年患者或糖尿病患者,以及既往有抗生素暴露史的患者。COVID-19痊愈后的积脓可能与慢性病炎症改善延迟有关,这导致患者更容易发生继发感染。